Back
Surgery Partners Vs. Biomarin Pharmaceutical Industry Stock Comparison
Buy
64
SGRY
Surgery Partners
Last Price:
30.33
Seasonality Move:
31.25%
Buy
61
BMRN
Biomarin Pharmaceutical
Last Price:
67.07
Seasonality Move:
13.3%
Buy
64
Surgery Partners (SGRY)
is a Buy
Is Surgery Partners a Buy, Sell or Hold?
- The current Surgery Partners [SGRY] share price is $30.36. The Score for SGRY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- SGRY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $67.07. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SGRY Stock Price Chart
What is Surgery Partners's stock price today?
-
The Surgery Partners share price today is $30.36
The current trend is relatively stagnant and SGRY is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $67.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
SGRY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 49.4 | Sell |
| Chaikin Money Flow: | 494252 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.31 - 31.63) | Sell |
| Bollinger Bands (100): | (26.58 - 32.2) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.77 | Sell |
| Relative Strength Index (14 RSI): | 36.99 | Sell |
| Chaikin Money Flow: | 38184 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.11 - 70.53) | Sell |
| Bollinger Bands (100): | (70.87 - 88.17) | Sell |
SGRY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.49 | Buy |
| 20-day SMA: | 30.55 | Sell |
| 50-day SMA: | 31.01 | Sell |
| 200-day SMA: | 28.81 | Buy |
| 8-day EMA: | 29.89 | Buy |
| 20-day EMA: | 30.25 | Buy |
| 50-day EMA: | 30.42 | Sell |
| 200-day EMA: | 29.69 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.42 | Buy |
| 20-day SMA: | 68.68 | Sell |
| 50-day SMA: | 73.15 | Sell |
| 200-day SMA: | 82.32 | Sell |
| 8-day EMA: | 67.03 | Buy |
| 20-day EMA: | 68.41 | Sell |
| 50-day EMA: | 72.52 | Sell |
| 200-day EMA: | 80.98 | Sell |
Surgery Partners Earnings Growth & SGRY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.24 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.
Surgery Partners Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||